Fecal microbiota transplantation: can it circumvent resistance to PD-1 blockade in melanoma?
Signal Transduct Target Ther
.
2021 May 8;6(1):178.
doi: 10.1038/s41392-021-00585-5.
Authors
Lisa Derosa
1
2
3
,
Laurence Zitvogel
4
5
6
7
8
9
Affiliations
1
Gustave Roussy Comprehensive Cancer Institute, Clinicobiome, Villejuif, France. deros.lisa@gmail.com.
2
Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France. deros.lisa@gmail.com.
3
INSERM U1015, Villejuif, France. deros.lisa@gmail.com.
4
Gustave Roussy Comprehensive Cancer Institute, Clinicobiome, Villejuif, France. laurence.zitvogel@orange.fr.
5
Faculty of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France. laurence.zitvogel@orange.fr.
6
INSERM U1015, Villejuif, France. laurence.zitvogel@orange.fr.
7
Equipe labellisée par la Ligue contre le cancer, Villejuif, France. laurence.zitvogel@orange.fr.
8
Center of Clinical Investigations in Biotherapies of Cancer (CICBT) BIOTHERIS, Villejuif, France. laurence.zitvogel@orange.fr.
9
Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China. laurence.zitvogel@orange.fr.
PMID:
33966043
PMCID:
PMC8106675
DOI:
10.1038/s41392-021-00585-5
No abstract available
Publication types
Comment
MeSH terms
Fecal Microbiota Transplantation*
Humans
Melanoma* / drug therapy
Programmed Cell Death 1 Receptor
Substances
Programmed Cell Death 1 Receptor